PACAP expression in explant cultured mouse major pelvic ganglia.
The major pelvic ganglia (MPG) contain both parasympathetic and sympathetic postganglionic neurons and provide much of the autonomic innervation to urogenital organs and components of the lower bowel. Whereas many parasympathetic neurons were found to express vasoactive intestinal polypeptide (VIP), no MPG neurons exhibited immunoreactivity for pituitary adenylate cyclase-activating polypeptide (PACAP). However, in 3-day cultured MPGs, numerous PACAP-IR cells and nerve fibers were present, and transcript levels for PACAP increased significantly. In 3-day cultured MPGs, PACAP immunoreactivity was seen in cells that were also immunoreactive for VIP or neuronal nitric oxide synthase, but not tyrosine hydroxylase, indicating that PACAP expression occurred preferentially in MPG parasympathetic postganglionic neurons. Transcript levels for the VPAC2, but not VPAC1 or PAC1 receptor, also increased significantly following 3 days in culture. Transcript levels of activating transcription factor 3 (ATF-3), a marker of cellular injury, were increased 64-fold in 3-day explants, and ATF-3-IR nuclei were evident in both TH-IR and nNOS-IR neurons as well as in non-neuronal cells. In sum, these results demonstrate that, although only the parasympathetic neurons in explant cultured MPGs increase expression of PACAP, both sympathetic and parasympathetic postganglionic neurons in the cultured MPG whole-mount increase expression of ATF-3.
Girard
Beatrice M
BM
Departments of Anatomy and Neurobiology, College of Medicine, University of Vermont, Burlington, VT 05405, USA.
Galli
Jonathan R
JR
Young
Beth A
BA
Vizzard
Margaret A
MA
Parsons
Rodney L
RL
D051700:Activating Transcription Factor 3 / Q000235:genetics / Q000378:metabolism; D000818:Animals; D005726:Ganglia, Parasympathetic / Q000166:cytology / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000235:genetics / Q000378:metabolism*; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / Q000235:genetics / Q000378:metabolism; D051239:Receptors, Vasoactive Intestinal Peptide, Type II / Q000235:genetics / Q000378:metabolism; D051238:Receptors, Vasoactive Intestinal Polypeptide, Type I / Q000235:genetics / Q000378:metabolism; D046509:Tissue Culture Techniques; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D051700:Activating Transcription Factor 3; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; D051239:Receptors, Vasoactive Intestinal Peptide, Type II; D051238:Receptors, Vasoactive Intestinal Polypeptide, Type I; D052248:Nitric Oxide Synthase Type I; D014446:Tyrosine 3-Monooxygenase
Cell Tissue Res. 1996 Aug;285(2):281-6
8766164
Mol Cell Neurosci. 2000 Feb;15(2):170-82
10673325
J Comp Neurol. 2000 Oct 23;426(3):493-504
10992251
J Neurosci. 1993 Apr;13(4):1642-53
8463841
Int Rev Cytol. 2006;248:141-208
16487791
Peptides. 2004 Mar;25(3):393-401
15134862
J Neurochem. 2006 Oct;99(2):499-513
17029602
J Neurobiol. 1994 Feb;25(2):108-18
7517435
Regul Pept. 2002 Nov 15;109(1-3):89-101
12409220
Eur J Neurosci. 2006 Sep;24(6):1555-64
17004919
J Biol Chem. 1999 Sep 24;274(39):27702-10
10488112
Mol Cell Neurosci. 2006 May-Jun;32(1-2):143-54
16713293
J Neurosci. 2007 Jul 25;27(30):7911-20
17652582
J Neurobiol. 2004 May;59(2):216-35
15085539
J Comp Neurol. 2008 Jun 10;508(5):795-805
18393382
J Comp Neurol. 2000 Jul 17;423(1):26-39
10861534
J Mol Neurosci. 2008 Nov;36(1-3):175-87
18561033
Neuroscience. 2007 May 11;146(2):584-93
17367946
Brain Res. 1997 Nov 14;775(1-2):166-82
9439840
J Mol Neurosci. 2010 Nov;42(3):390-6
20428965
J Neurosci. 2003 Jun 15;23(12):5187-96
12832543
Neuroscience. 2007 Dec 19;150(4):887-97
18031939
Cell Tissue Res. 2003 Feb;311(2):175-85
12596037